SCHEMBL4773443

SCHEMBL4773443

O=CC(S)C(c1cccc(Cl)c1)N1CCN(C(=O)c2cc(F)ccc2C(F)(F)F)CC1

nearest known ligand 0.42

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HDAC8 Q9BY41 1/20 0.42
SCN5A Q14524 4/20 0.41
SCN9A Q15858 4/20 0.41
P2RX7 Q99572 5/20 0.38
PSEN1 P49768 1/20 0.38
PSEN2 P49810 1/20 0.38
APH1B Q8WW43 1/20 0.38
NCSTN Q92542 1/20 0.38
APH1A Q96BI3 1/20 0.38
PSENEN Q9NZ42 1/20 0.38
ALDH1A1 P00352 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
HTT P42858 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
SCD O00767 1/20 0.37
HCRTR1 O43613 1/20 0.36
HCRTR2 O43614 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4774662 0.79 CACNA1B (0.41) HDAC8SCN5ASCN9AALDH1A1L3MBTL1
SCHEMBL4775889 0.76 SCN5A (0.42) HDAC8SCN5ASCN9AP2RX7PSEN1
SCHEMBL4753765 0.75 HCRTR1 (0.44) HDAC8SCN5ASCN9AP2RX7PSEN1
SCHEMBL4905083 0.75 HDAC8 (0.62) HDAC8SCN5ASCN9AP2RX7PSEN1
Hydrochloric Acid SCHEMBL3466376 0.74 HCRTR1 (0.43) HDAC8SCN5ASCN9AP2RX7PSEN1
SCHEMBL4772658 0.74 CACNA2D1 (0.39) SCN5ASCN9AP2RX7PSEN1PSEN2
SCHEMBL4905417 0.71 HDAC8 (0.80) HDAC8SCN5ASCN9AP2RX7ALDH1A1
SCHEMBL4905399 0.71 HDAC8 (0.80) HDAC8SCN5ASCN9AP2RX7ALDH1A1
SCHEMBL4778523 0.70 SCD (0.40) P2RX7SCD
SCHEMBL4780056 0.69 SCD (0.38) ALDH1A1L3MBTL1SMN1; SMN2SCD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1996550-A2 CARBOXYAMINE COMPOUNDS AND THEIR USE IN THE TREATMENT OF HDAC DEPENDENT DISEASES Novartis AG (CH) 2008-12-03 EP claimed
WO-2007038459-A2 CARBOXYAMINE COMPOUNDS AND THEIR USE IN THE TREATMENT OF HDAC DEPENDENT DISEASES NOVARTIS AG (CH) 2007-04-05 WO claimed